Macrocyclic inhibitors of flaviviridae viruses
US8933015B2 · kind B2 · utility
6Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 15, 2013 |
| Grant date | Jan 13, 2015 |
| Priority date | — |
| Expiry date | Jul 15, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06052
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compounds of Formula I:and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.